HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Quantitation of T-cell neogenesis in vivo after allogeneic bone marrow transplantation in adults.

Abstract
Following myeloablative therapy, it is unknown to what extent age-dependent thymic involution limits the generation of new T cells with a diverse repertoire. Normal T-cell receptor gene rearrangement in T-cell progenitors results in the generation of T-cell receptor rearrangement excision circles (TRECs). In this study, a quantitative assay for TRECs was used to measure T-cell neogenesis in adult patients with leukemia who received myeloablative therapy followed by transplantation of allogeneic hematopoietic stem cells. Although phenotypically mature T cells had recovered by 1 to 2 months after bone marrow transplantation (BMT), TREC levels remained low for 3 months after BMT. T-cell neogenesis became evident by 6 months, and normal levels of adult thymic function were restored at 6 to 12 months after BMT. Subsequent leukemia relapse in some patients was associated with reduced TREC levels, but infusion of mature donor CD4(+) T cells resulted in rapid restoration of thymic function. These studies demonstrate that T-cell neogenesis contributes to immune reconstitution in adult patients and suggest that thymic function can be manipulated in vivo. (Blood. 2001;98:1116-1121)
AuthorsE P Hochberg, A C Chillemi, C J Wu, D Neuberg, C Canning, K Hartman, E P Alyea, R J Soiffer, S A Kalams, J Ritz
JournalBlood (Blood) Vol. 98 Issue 4 Pg. 1116-21 (Aug 15 2001) ISSN: 0006-4971 [Print] United States
PMID11493459 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Topics
  • Adult
  • Bone Marrow Transplantation (methods)
  • Case-Control Studies
  • Cell Differentiation (immunology, physiology)
  • Female
  • Gene Rearrangement, T-Lymphocyte (physiology)
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive (therapy)
  • Leukopoiesis (immunology)
  • Lymphocyte Depletion
  • Male
  • Middle Aged
  • T-Lymphocytes (physiology)
  • Time Factors
  • Transplantation Conditioning
  • Transplantation, Homologous (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: